Tagged: nutraceuticals
12 results
BOTALYS
BOTALYS is a Belgian botanical-ingredients company that grows rare medicinal plants, starting with Korean ginseng, inside one of Europe's largest indoor vertical farms. Using a proprietary Biomimetic Indoor Farming method, it recreates the harsh wild conditions that make plants build up active compounds, harvesting ginseng in months rather than years and producing roots with unusually high concentrations of ginsenosides. Its ultra-pure, standardized extracts - led by the HRG80 ginseng ingredient - supply nutraceutical, cosmetic and pharmaceutical companies looking for traceable, contaminant-free botanicals.
Pierre-Antoine Mariage
Pierre-Antoine Mariage is the founder and CEO of Botalys, a Belgian agtech company that grows rare medicinal plants like Korean ginseng and Fjord Rhodiola indoors using a proprietary hydroponic technology, supplying ultra-pure botanical ingredients to the nutraceutical, cosmetic and pharmaceutical industries.
Elevated Signals
Elevated Signals is a Vancouver-based software company building modern, cloud-based manufacturing operations software for highly regulated industries. Born out of the Canadian cannabis boom, its platform replaces paper, spreadsheets, and legacy ERPs with a single real-time source of truth across inventory, quality, traceability, planning, costing, manufacturing, and fulfillment. After raising a $7.9M CAD Series A led by Yaletown Partners in 2024, the company is expanding beyond cannabis into nutraceuticals, food and beverage, CPG, and critical minerals.
Intiva Health
Intiva Health is an Austin-based healthcare technology company that grew out of a 2006 surgical-staffing agency into a group of businesses tied together by medical credentialing. Its flagship product, Incredable (formerly Ready Doc), is a distributed-ledger-based platform that turns credential verification - the paperwork that decides which clinicians are allowed to work - from a months-long process into a near-instant, tamper-evident one. The company has since layered on a crypto token (TIVA) to run payments and rewards inside that platform, plus sibling ventures in supplement manufacturing (Gummi World) and wellness clinics (Nova Vita).
OXOMIO
OXOMIO is a luxury wellness company that makes fermented supplements and nutricosmetics for gut, skin, hair and general health. Founded in 2017 by David Friedeberg, it uses a proprietary bio-fermentation process (GPM - Glycoprotein Matrix) to produce highly bioavailable organic vitamins and minerals, and combines them with branded ingredients such as Peptan marine collagen, LactoSpore probiotics and Superba Boost krill oil. It sells direct-to-consumer online under the tagline 'The Luxury of Wellness.'
People Science
People Science is a Los Angeles clinical research organization that turns rigorous clinical trials into software. Its platform, Chloe, lets wellness and health brands design, launch, and run decentralized, IRB-approved studies entirely from participants' homes - integrating wearables, lab partners, and remote data collection so that supplements, nutraceuticals, cannabinoids, psychedelics, and food-as-medicine products can earn real clinical evidence at a fraction of the cost and time of a traditional CRO. Founded by MD-PhD co-CEOs Belinda Tan and Noah Craft, who previously built Science 37 into a billion-dollar clinical trials company, People Science aims to bring evidence to an industry long defined by claims.
Alexander Candelario
Alexander C. Candelario is the founder, CEO, and chairman of Intiva Health, an Austin-based healthcare company that began by rebuilding medical credentialing and has since grown into a multi-vertical group spanning the Incredable credentialing platform, the Nova Vita wellness centers, and Gummi World nutraceutical manufacturing. A CPA-trained forensic accountant and roughly 15-year Marine Corps veteran who rose from enlisted Force Recon to commissioned officer, he carries an unusual mix: combat-tested discipline, big-firm audit rigor from his Coopers & Lybrand days, and degrees from Texas A&M and Harvard. In 2025 he pushed credentialing onto the blockchain with the TIVA token, listed on MEXC Global, betting that verified professional trust can extend far beyond medicine.
David Friedeberg
David Friedeberg is the founder and CEO of OXOMIO, a wellness and supplements company that pairs Earth's purest natural ingredients with biotechnology under the banner 'The Luxury of Wellness.' Son of Mexican surrealist Pedro Friedeberg, David grew up in an artist's household where making something from nothing was a daily ritual, then carried that mindset through a career that spanned fine-art dealing, hospitality operations, and a Harvard MBA before launching OXOMIO in 2017. He splits his life between San Miguel de Allende, Mexico and Austin, Texas, and runs his days by the Japanese principle of kenkou dai-ichi - health above everything else.
Simon Cheng
Simon Cheng is the founder and CEO of Pique, a Los Angeles-based wellness company that turned whole-leaf tea into dissolvable crystals using a patented cold extraction process. A Hong Kong native who grew up drinking tea with his grandparents, Cheng abandoned those rituals in his teens, then spent his 20s cycling through surgeries and a decade of health crises. He rebuilt his health on a multi-year study trip across Asia learning from medicinal-plant and breathwork masters, and channeled that obsession into Pique, which launched in Whole Foods in 2016 and scaled to thousands of stores. Harvard and Stanford educated, and the youngest member of Harvard School of Public Health's Nutrition Roundtable, Cheng built Pique on three promises: efficacy, purity, and zero prep.
MetaNovas AI
MetaNovas (MetaNovas Biotech) is an AI-driven biotech company building a drug and disease discovery platform that compresses the slow, failure-prone front end of R&D. Its stack of proprietary engines - MetaNLP, MetaKG, MetaOmics and MetaPep - reads millions of scientific documents, maps biomedical knowledge, and designs bioactive peptides before anything reaches a lab bench. The company applies that science to longevity beauty, cosmeceuticals, medical aesthetics and functional foods, working with global brands while pursuing novel targets, drug repurposing and precision-formulated consumer health products.
Meijie Wang
Meijie Wang is the co-founder and CEO of MetaNovas, an AI-driven biotech that designs functional peptides for skincare, supplements and drug discovery. A former NVIDIA AI infrastructure engineer who built VR games and worked on AI at Stanford's School of Medicine, he now runs a Silicon Valley and Shanghai operation whose knowledge-graph platform aims to compress the decade-long hunt for new bioactive ingredients into something far shorter. MetaNovas counts L'Oreal, Beiersdorf, Haleon, Takeda and Unilever among its partners and raised a Series A led by GL Ventures.
Biohm Technologies
Biohm Technologies is a Cleveland-based microbiome innovation company that studies the gut as a whole - bacteria and fungi together - rather than bacteria alone. Built on 40+ years of fungal research by Dr. Mahmoud Ghannoum, the scientist who named the mycobiome, Biohm develops data-driven biotic ingredients and gut-health testing solutions. Its flagship ingredient Mycohsa is the first probiotic blend clinically shown to break down digestive biofilms, and its Symbiont discovery platform mines a large bacterial-fungal dataset to design targeted microbiome products. After a B2B pivot in 2024, the company now sells ingredients and microbiome science to nutraceutical and food brands.